Market Movers Today: Biohaven Pharmaceutical Holding Co Ltd (BHVN), Facebook, Inc. (FB), Longfin Corp (LFIN), Verona Pharma PLC – ADR (VRNA), and More

USG Corporation (NYSE:USG) (Yahoo Finance)
USG Corp (USG): Shares are climbing today, up around 15.9%. Berkshire Hathaway revealed that it proposed selling its approximately 30% stake in the building materials company to Germany’s Knauf group, for $42 a share.

Microsoft Corporation (NASDAQ:MSFT) (CNBC)
“Strong positioning for ramping public cloud adoption, large distribution channels and installed customer base, and improving margins support a path to $50 billion in EBIT and a $1 trillion market cap for MSFT,” Morgan Stanley’s Keith Weiss wrote in a note to clients Monday. The investment bank raised its one-year price target from $110 to $130, 49 percent higher than where the stock closed on Friday. At $130, Microsoft would be worth $1 trillion. Its current market value is $671 billion, behind Apple at $856 billion, Amazon at $747 billion and Alphabet at $730 billion. Shares of Microsoft rose more than 5.5 percent following Morgan Stanley’s call.

DarioHealth Corp (NASDAQ:DRIO) (MarketWatch)
Shares of DarioHealth Corp. DRIO, +22.86% are up 29% in premarket trading Monday after the company said it had received FDA clearance for its blood glucose monitoring system to be used on Apple Inc. AAPL, +3.33% iPhone 7, 8, and X devices via the Lightning port on these phones. The monitor also works with a 3.5mm headphone jack. “With today’s news, DarioHealth plans to expand U.S. sales in the coming weeks,” the company said in a release.

Protagonist Therapeutics Inc (NASDAQ:PTGX) (Benzinga)
Protagonist Therapeutics, Inc. shares tumbled 56.4 percent to $8.90 as the company disclosed that it has discontinued Phase 2b PROPEL trial of PTG-100 for the treatment of ulcerative colitis following interim analysis.

Finish Line Inc (NASDAQ:FINL) (Yahoo Finance)
Finish Line (FINL): Shares soaring in early trade, up around 29%. The athletic retailer agreed to be bought by JD Sports Fashion for $13.50 a share, or $558 million.